BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22749133)

  • 1. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
    Androutsopoulos VP; Spandidos DA
    J Nutr Biochem; 2013 Feb; 24(2):496-504. PubMed ID: 22749133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 Cells.
    Liu B; Jia K; Yang Y; Hao S; Lu C; Xu F; Feng D; Zhu R
    Protein Pept Lett; 2017 May; 24(5):406-412. PubMed ID: 28245756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signaling proteins and CYP1-mediated metabolism.
    Androutsopoulos VP; Tsatsakis AM
    Toxicol Lett; 2014 Oct; 230(2):304-13. PubMed ID: 23994263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450.
    Androutsopoulos V; Wilsher N; Arroo RR; Potter GA
    Cancer Lett; 2009 Feb; 274(1):54-60. PubMed ID: 18976853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antiproliferative Activity of Oxypeucedanin via Induction of G
    Park SH; Hong JY; Park HJ; Lee SK
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells.
    Cho JH; Lee JG; Yang YI; Kim JH; Ahn JH; Baek NI; Lee KT; Choi JH
    Food Chem Toxicol; 2011 Aug; 49(8):1737-44. PubMed ID: 21554918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
    Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
    Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
    Han J; Kim S; Yang JH; Nam SJ; Lee JE
    Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
    Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
    J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the JNK activation in terbinafine-induced p21 up-regulation and DNA synthesis inhibition in human vascular endothelial cells.
    Hsu SP; Ho PY; Liang YC; Ho YS; Lee WS
    J Cell Biochem; 2009 Nov; 108(4):860-6. PubMed ID: 19693773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
    Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.
    Androutsopoulos VP; Mahale S; Arroo RR; Potter G
    Oncol Rep; 2009 Jun; 21(6):1525-8. PubMed ID: 19424633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells.
    Liu B; Zhang M; Liu S; Ying J; Zhang J; Kurihara H; Zheng W; He RR; Zhu R
    Protein Pept Lett; 2017; 24(5):413-418. PubMed ID: 28240165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the ERK phosphorylation plays a role in terbinafine-induced p21 up-regulation and DNA synthesis inhibition in human vascular endothelial cells.
    Ho PY; Hsu SP; Liang YC; Kuo ML; Ho YS; Lee WS
    Toxicol Appl Pharmacol; 2008 May; 229(1):86-93. PubMed ID: 18272192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer pyridines induce G2/M arrest and apoptosis via p53 and JNK upregulation in liver and breast cancer cells.
    Androutsopoulos VP; Spandidos DA
    Oncol Rep; 2018 Feb; 39(2):519-524. PubMed ID: 29207138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
    Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
    Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells.
    Qu K; Lin T; Wei J; Meng F; Wang Z; Huang Z; Wan Y; Song S; Liu S; Chang H; Dong Y; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1253-9. PubMed ID: 24067199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.